Annual Report 2014-2015 > HIV & STIs

    The Bixby Center is transforming HIV/AIDS prevention, treatment and care through our innovative research and programs worldwide. Here are some of our noteworthy achievements in HIV and sexually transmitted infections (STIs) over the past year:
  • We provided support for research in Zimbabwe that showed early antiretroviral therapy prevents sexual transmission of HIV from infected men and women to their HIV-uninfected partners.
  • We are supporting the launch of the first HIV vaccine clinical trial in Zimbabwe.
  • We’re helping lead the development of guidelines for cervical cancer screening and treatment for women living with HIV.14
  • We developed a model for understanding how migration contributes to HIV risks in women in Africa, highlighting potential opportunities for HIV prevention.15

We collaborate with partners in Kenya to provide family-centered, comprehensive and compassionate HIV care. We’re building a foundation for long-term, sustainable treatment for more than 85,000 clients, 92 percent of whom receive life-saving antiretroviral therapy.

To learn more about our programs working in HIV/AIDS, see Family AIDS Care & Education Services (FACES) and the UCSF-University of Zimbabwe Collaborative Research Programme (UZ-UCSF).

To help us continue making an impact on HIV/AIDS treatment, care and prevention worldwide, make a gift to the Bixby Center